Emcure and Roche join forces to expand kidney and transplant drug access in India
Emcure and Roche join forces to expand kidney and transplant drug access in India
Emcure and Roche join forces to expand kidney and transplant drug access in India
Emcure Pharmaceuticals has partnered with Roche to distribute key nephrology and transplant medicines across India. The agreement, set to begin on 1 April 2026, will expand access to treatments for chronic kidney disease, anemia symptoms, and organ transplants. Both companies aim to improve patient care through wider availability of these specialised drugs.
Under the deal, Emcure will market and distribute Roche's established brands in India. These include CellCept, an immunosuppressant used in organ transplants, as well as Mircera and Neorecormon, which treat anemia in patients with chronic kidney disease. Mircera, a long-acting erythropoiesis-stimulating agent (ESA), requires dosing only once every two to four weeks.
Rajji Mehdwan, Managing Director and CEO of Roche India & Neighbouring Markets, highlighted Emcure's strong distribution network and clinical engagement. She noted that these strengths would help ensure the medicines reach more patients in need. Satish Mehta, Managing Director and CEO of Emcure Pharmaceuticals, added that the partnership aligns with his company's focus on improving outcomes in anemia and renal care.
The collaboration will cover nationwide distribution, though no public data exists on how many doctors or clinics currently use Roche's nephrology and transplantation medicines in India.
The agreement will take effect from 1 April 2026, marking a step toward broader access to critical treatments. Patients with chronic kidney disease, anemia symptoms, and transplant needs may benefit from improved availability of Roche's specialised drugs. The partnership combines Emcure's distribution reach with Roche's established therapies in these areas.
How Prebiotics Transform Gut Health Through Whole Foods
Your gut's best allies may already be in your kitchen. These natural compounds quietly fuel microbes that protect, heal, and energize your body.
Georgian parents fight for life-saving drugs for children with Duchenne dystrophy
In freezing Tbilisi, desperate parents refuse to back down. Their children's lives depend on drugs the state won't import—why the delay?
Long flights pose hidden health risks for vulnerable passengers
Your next long flight could be riskier than you think. Discover the simple steps doctors say can protect your health at 30,000 feet.
Kauvery Hospital's ECG Masterclass trains 400+ professionals in cardiac care
A landmark event for cardiology education unfolds as experts and trainees unite. New ECG handbook debuts to elevate global cardiac care standards.